WecLac® Individual Clinical Strains-Wecare Probiotics

Home
Products
Products

We are leaders in microbiome research, with a focus on probiotic strains, starter cultures, and the influence of beneficial microbial communities on diverse hosts, including humans, animals, and plants.
News
News

We actively participate in international probiotic industry seminars and conferences, sharing our research results and industry insights with leading experts and peers around the world.
- Company News
- Industry Insight
About Us
About Us

We are leaders in microbiome research, with a focus on probiotic strains, starter cultures, and the influence of beneficial microbial communities on diverse hosts, including humans, animals, and plants.
Founder
Founder

We actively participate in international probiotic industry seminars and conferences, sharing our research results and industry insights with leading experts and peers around the world.
- Dr. Frank Fang
Contact Us
Contact Us

We welcome the opportunity to connect with you, share more insights, explore potential partnerships, and work together to drive innovation and growth in the probiotic industry.
- Contact Us
- Join Us

English Français Español Русский

Home > Products > WecLac^® Individual Clinical Strains > Weizmannia coagulans

Weizmannia coagulansBC99

Potency

300B CFU/g

Source of Strain

Healthy infant intestines

Deposit Number

PTA-126829(ATCC) No.21801(CGMCC)

Functions

Gastrointestinal Health
Metabolic Health
Emotional Health
Maternal & Child Health
Immune Health
Oral Health

References

[1]Zhu M, Zhu J, Fang S, Zhao B. Complete genome sequence of Heyndrickxia (Bacillus) coagulans BC99 isolated from a fecal sample of a healthy infant. Microbiol Resour Announc. 2024 Jan 17;13(1):e0044923. doi: 10.1128/mra.00449-23. Epub 2023 Dec 14. PMID: 38095439; PMCID: PMC10793334.

[2]Wu Y, Bai Z, Jin Y, Zhu H, Dong Y, Gu S and Jin Y (2024) A randomized, double-blind, placebo-controlled clinical study to evaluate the efficacy and safety of Weizmannia coagulans BC99 in the treatment of chronic constipation in adults.Front. Nutr. 11:1395083.doi: 10.3389/fnut.2024.1395083。PMID：39119466

[3]A probiotic Bacillus coagulans and its application (ZL 202110285874.6)

[4]Application of Bacillus coagulans BC99 in the preparation of selenium rich drugs or food (ZL 202111586847.9)

[5]The use of Bacillus coagulans BC99 in the preparation of colitis relieving or immunomodulatory products (ZL 202210317985.5)

[6]A composite probiotic for anti anxiety and depression and its application (ZL 202410303118.5)

[7]A composite probiotic that promotes iron absorption and its application (ZL 202410225116.9)

[8]A probiotic agent for improving osteoporosis and its application(ZL 202410289009.2)

[9]A probiotic agent for improving spermatogenic disorders and its application(ZL 202410452391.4)

Introduction

Relieve colitis

Apply BC99 into the preparation of colitis relief products or immunomodulatory productsBC99 can regulate the intestinal immune function of mice and significantly reduce the pro-inflammatory factor TNF in thecolon tissue of mice-a. The content of lL-6 significantly increases the content of anti-inflammatory factor lL-10.